Recent Press Releases
CALGARY, AB – February 27, 2018 – XORTX Therapeutics Inc. (“XORTX” or the “Company”) (CSE:XRX), a biopharmaceutical company focused on developing innovative therapies to treat progressive kidney disease, is pleased to provide this corporate update.
“With the successful close of the Company’s recent merger with APAC Resources Inc.
› Read more
Recent Press Releases
CALGARY, Alberta, Feb. 22, 2018 (GLOBE NEWSWIRE) — XORTX Therapeutics Inc. (“XORTX” or the “Company”) (CSE:XRX), a biopharmaceutical company focused on developing innovative therapies to treat progressive kidney disease, is pleased to announce the appointment of Dave Matthews as Chief Financial Officer (“CFO”).
› Read more
Recent Press Releases
Vancouver, BC – January 10, 2018 – APAC Resources Inc. (“APAC”) (CSE:APG:CNX) and XORTX Pharma Corp. (“XORTX”) are pleased to announce the completion of the previously announced reverse take-over and acquisition by APAC of all of the issued and outstanding shares (“XORTX Shares”) of XORTX (the “Acquisition”).
› Read more
Recent Press Releases
CALGARY, Alberta, Jan. 29, 2018 (GLOBE NEWSWIRE) — XORTX Therapeutics Inc. (“XORTX” or the “Company”) (CSE:XRX), a BioPharmaceutical company focused on developing innovative therapies to treat progressive kidney disease, announces the appointment of Allan Williams and Paul Van Damme as directors of the Company and the resignation of Dr.
› Read more